B
Beta Bionics, Inc.
BBNX · NASDAQ · Healthcare · 790M
Closing price
$17.63
+1.15% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.5×
Enterprise value / EBITDAEV/EBITDA
-9.8×
Free cash flow yieldFCF yield
-7.9%
Return on equityROE
-25.5%
Operating margin
-71.5%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.